Discontinuation report TARO-DEFERASIROX
Report ID | 105036 |
Drug Identification Number | 02463547 |
Brand name | TARO-DEFERASIROX |
Common or Proper name | DEFERASIROX |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | DEFERASIROX |
Strength(s) | 500MG |
Dosage form(s) | TABLET FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | V03AC |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-01-31 |
Remaining supply date | 2020-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-02-02 | French | Compare |
v1 | 2020-02-02 | English | Compare |
Showing 1 to 2 of 2